Sankala Group LLC

SEC CIK: 0002113426
Latest filing: Aug 18, 2026

SEC filings (opens in a new tab)

RPRX holding history

Royalty Pharma plc in every 13F filed by Sankala Group LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RPRX overview All 13F holders of RPRX Full Q2 2026 holdings

Shares (Q2 2026): 197
Value: $11.8K
% of portfolio: <0.1%
Quarters held: 3; Since Q4 2025

Holdings of RPRX by Sankala Group LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	197	$11.8K	<0.1%	00.0%	Unchanged	Holders
Q1 2026	197	$9.30K	<0.1%	00.0%	Unchanged	Holders
Q4 2025	197	$9.10K	<0.1%	–	No prior filing	Holders